Clinical Trial: MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma

Brief Summary:

This research study is studying a targeted therapy as a possible treatment for merkel cell carcinoma.

- The name of the study intervention involved in this study is: MLN0128.